Workflow
以色列研究人员利用纳米技术提升CAR-T疗法抗癌疗效
news flash·2025-06-10 02:20

Core Viewpoint - Israeli researchers have developed a new artificial activation platform using nanotechnology, which is expected to significantly enhance the efficacy of CAR-T therapy in cancer treatment, particularly in improving T cell persistence and anti-cancer capabilities [1] Group 1: CAR-T Therapy Overview - CAR-T therapy involves extracting T cells from patients, genetically modifying them in the laboratory, and reinfusing them to identify and attack cancer cells, showing significant efficacy in treating certain hematological malignancies like leukemia [1] - A key challenge for CAR-T therapy is the limited duration of activity of CAR-T cells within the body [1] Group 2: Technological Advancements - The new platform developed by researchers at Ben-Gurion University of the Negev is based on nanotechnology derived from chip manufacturing, representing a major breakthrough in enhancing the effectiveness of CAR-T therapy [1]